{ "ok": true, "cik": "2011514", "ticker": "AVR", "name": "Anteris Technologies Global Corp.", "filings": [ { "form": "8-K", "filed": "2026-09-17", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126037002/0001140361-26-037002-index.htm" }, { "form": "8-K", "filed": "2026-09-08", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126035840/0001140361-26-035840-index.htm" }, { "form": "8-K", "filed": "2026-08-12", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126032296/0001140361-26-032296-index.htm" }, { "form": "10-Q", "filed": "2026-08-11", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126032232/0001140361-26-032232-index.htm" }, { "form": "8-K", "filed": "2026-08-03", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126030586/0001140361-26-030586-index.htm" }, { "form": "8-K", "filed": "2026-07-31", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/2011514/000114036126030355/0001140361-26-030355-index.htm" } ], "events12m": 26, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002011514.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2011514" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up Anteris Technologies Global Corp. ($AVR). Last filing: 8-K (5.02 Departure or Election of Directors; Appointment of Officers), 2026-09-17. 26 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 1913000, "revenueGrowth1y": -0.292267850536441, "revenueGrowthPerYear": null, "yearsOfData": 2, "operatingMargin": -49.08207004704652, "operatingMarginPrior": -28.994450610432853, "netMargin": -49.25509670674334, "operatingCashFlow": -77803000, "capitalSpending": 1954000, "freeCashFlow": -79757000, "researchAndDevelopment": 69120000, "researchShareOfRevenue": 36.13173026659697, "cash": 12576000, "longTermDebt": 38000, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2024-12-31", "revenue": 2703000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 1913000 } ], "totalEquity": -93000, "totalAssets": 22997000, "equityRatio": -0.004044005739879114, "returnOnEquity": null, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 993621.0466518684, "high": 1784158.3530151686, "baseline": 1353891.6019237884, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 993621.0466518684, "high": 1784158.3530151686 } }, "edgarette": "🔖 Exposure: revenue $1.9M (FY2025), total debt $38K. Experience: revenue down 29.2% on the year; operating margin -4908.2%, down from -2899.4%. Soundness: equity -0.4% of assets (liabilities exceed assets). Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $994K and $1.8M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin -4908.2% against a 11.0% median; growth -29.2% against 7.5%.", "peers": { "sic": 3842, "sicDescription": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3842", "growth": [ 0.0753, 13 ], "opMargin": [ 0.1104, 13 ], "equityRatio": [ 0.6294, 12 ], "returnOnEquity": [ 0.1026, 12 ] }, "summary": "Anteris Technologies Global (AVR) saw revenue fall 29.2% in FY2025 to $2 million, operating margin -4908% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity -0.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
Anteris Technologies Global Corp. against its own record and its peers
Operating marginPeer median 11.0%-4908.2%Revenue, on the yearPeer median 7.5%-29.2%Equity of assetsPeer median 62.9%-0.4%Gold tick: the median of 12–12 peers with $50M+ revenue in orthopedic, prosthetic & surgical appliances & supplies
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T14:04:17.672Z", "hash": "70ca72aaf09f49a2", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Anteris Technologies Global (AVR) saw revenue fall 29.2% in FY2025 to $2 million, operating margin -4908% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity -0.4% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 1913000, "totalDebt": 38000, "cash": 12576000 }, "experience": { "revenueGrowth1y": -0.292267850536441, "revenueGrowthPerYear": null, "operatingMargin": -49.08207004704652, "operatingMarginPrior": -28.994450610432853, "netMargin": -49.25509670674334, "freeCashFlow": -79757000 }, "soundness": { "equityRatio": -0.004044005739879114, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3842, "sicDescription": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3842", "growth": [ 0.0753, 13 ], "opMargin": [ 0.1104, 13 ], "equityRatio": [ 0.6294, 12 ], "returnOnEquity": [ 0.1026, 12 ] }, "credibility": { "auditedYears": 2, "weight": "moderate", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "range": { "low": 993621.0466518684, "high": 1784158.3530151686, "baseline": 1353891.6019237884, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T14:04:17.672Z", "hash": "70ca72aaf09f49a2", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002011514.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2011514" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }